No Data
No Data
Express News | Canaccord Genuity Assumes OrganiGram Holdings at Speculative Buy, Announces Price Target of C$3.25
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.38
CCORF analyst Matt Bottomley maintains $OrganiGram(OGI.US)$ with a buy rating, and maintains the target price at $2.38.According to TipRanks data, the analyst has a success rate of 45.1% and a total
OrganiGram Holdings Switches Auditors Amidst Industry Shift
OrganiGram | 6-K: Report of foreign private issuer (related to financial reporting)
Marijuana Stock Movers For July 11, 2024
GAINERS:Australis Capital (OTC:AUSAF) shares closed up 9900.00% at $0.0001Cara Therapeutics (NASDAQ:CARA) shares closed up 25.84% at $0.374Front Ventures (OTC:FFNTF) shares closed up 23.42% at $0.10
A $2 Billion Opportunity In Cannabis: How A Tobacco Giant Is Helping Organigram Seize The German Market
On July 10, Zuanic & Associates hosted a panel discussion focusing on the European cannabis market, featuring Benna Goldenberg, CEO of Organigram Holdings (NASDAQ:OGI), and Finn Age Hansel, CEO of